If your heartburn symptoms are not improving with lifestyle changes or OTC medications, it is a clear sign to contact your doctor
Compared to naltrexone or topiramate, semaglutide was associated with a significantly lower risk of incident AUD diagnosis (0.35% vs 0.78%
Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively

Washington We accept major insurance plans from: Virginia We accept major insurance plans from: Texas We accept major insurance plans from: Oregon We accept major insurance plans from: Ohio We accept major insurance plans from: North Carolina We accept major insurance plans from: New York We accept major insurance plans from: New Jersey We accept major insurance plans from: Michigan We accept major insurance plans from: Minnesota We accept major insurance plans from: Indiana We accept major insurance plans from: Kentucky We accept major insurance plans from: Illinois We accept major insurance plans from: Idaho We accept major insurance plans from: Hawaii We accept major insurance plans from: Georgia We accept major insurance plans from: California We accept major insurance plans from: Florida We accept major insurance plans from: Colorado We accept major insurance plans from: Arizona We accept major insurance plans from: States name goes here We're actively working to accept insurance in your state

This week, lets talk about another nutrient that deserves just as much attention: fiber